Aptar Pharma

Aptar Pharma's PremiumCoat® offers state-of-the-art ETFE-coated stoppers and plungers, combining superior container closure integrity and compatibility. With its highest standard specifications, it ensures optimal particulate protection for sensitive drugs.

Aptar Pharma's Unidose systems are nasal drug delivery devices for both liquid and powder forms, enabling precise single-dose delivery without healthcare professional intervention.

Aptar Pharma offers nasal vaccine solutions, suitable for liquid and powder formulations, that ensure precise dosing and ease of use for healthcare professionals. These non-injectable alternatives potentially decrease cold chain storage needs, enhancing distribution.

Aptar Pharma's Bidose (BDS) is a two-shot, user-friendly nasal delivery device for liquid drugs. This sturdy, self-priming system permits accurate, one-handed operation, enabling non-invasive, systemic drug delivery without the assistance of a healthcare professional.

Aptar Pharma’s BAI is a user-friendly, breath-activated pMDI, that enhances adherence across all patient types, including children and the elderly. Suitable even for those with low inspiration rates, it ensures consistent dosage by delivering each dose upon inhalation at the mouthpiece. 

The revision of the European Medical Agency annex 1 of the GMP poses new challenges for Pharma manufacturers who have to implement a contamination control and sterility assurance strategies. Aptar Pharma Injectables’ Advanced Solutions perfectly combine to support our Pharma partners in tackling these new stringent requirements: PremiumFill®: Enhanced manufacturing means designed to deliver higher quality products with improved specifications, especially on contamination criteria, to boost your Contamination Control Strategy RTP bags: the new standard for avoiding contamination on aseptic filling lines, highly recommended in the Annex 1 revision Ready-to-Use Gamma: the only 100% guarantee of sterility at the time of use as requested in the Annex 1 revision

"Globally circularity is on top of consumers’ minds, and this is no different when it comes to pharmaceutical packaging. Hence, plastic materials are increasingly under scrutiny. For drug delivery systems, regulatory demand for patient safety strongly limits the use of mechanically recycled materials, and alternatives are required that make drug packaging more circular. Aptar Pharma’s Futurity™ platform of sustainable drug delivery solutions enhances circularity in pharmaceutical packaging, without compromising on performance and safety. Following the recent launch of APF Futurity™, the first metal-free, highly recyclable nasal spray pump, we are expanding our range adding the fully-recyclable Micro+ Futurity™ for dermal drug application. Created from monomaterial polyethylene, Micro+ Futurity™ leverages the user convenience and medical grade material selection of Aptar Pharma’s Airless+ dispensing solutions.
Join Aptar Pharma’s session to learn how our Futurity™ platform can strengthen your circular approach with innovative drug dispensing solutions.